Acne with Solid Facial Edema
Acne with solid facial edema, also known as Morbihan disease, is a rare chronic inflammatory complication that develops on a background of acne or rosacea. It is marked by firm, non-pitting swelling with persistent redness, mainly over the central and upper face: the forehead, eyelids, cheeks, nose, and the area between the eyebrows. The condition tends to persist indefinitely, rarely settles on its own, and carries a high risk of distorting facial contours without early medical treatment.
The disease process combines chronic damage to small blood vessels with failure of the face's lymphatic drainage:
- Breakdown of supporting tissue and lymphatic blockage: Deep, chronic inflammation around the hair follicles and oil glands in acne destroys the extracellular matrix and the connective tissue scaffold that supports the small lymphatic vessels in the dermis. Without that support, the lymphatics collapse and their walls lose integrity, so lymph can no longer flow normally and protein-rich fluid leaks into the surrounding tissue.
- Mast cell infiltration and fibrosis: Biopsy studies show a marked increase in mast cells in the reticular dermis. The substances they release, including histamine and pro-fibrotic cytokines, drive fibroblasts to produce excess collagen locally. This collagen wraps tightly around the trapped lymph, turning what began as soft, fluctuating swelling into solid, permanent, non-pitting edema.
- Chronic vessel dilation: Ongoing inflammation causes irreversible widening of the superficial facial blood vessels. Their increased leakiness pushes more fluid into the tissues, keeping constant pressure on an already failing lymphatic system and sustaining the chronic swelling.
At Haute-Derma, our main goals in treating Morbihan disease are to switch off the deep vascular inflammation, help clear the trapped tissue fluid, and prevent further fibrosis so that the patient's facial appearance is preserved.
Our Approach to Managing Morbihan Disease at Haute-Derma
Controlling Morbihan disease requires close coordination between medications that regulate the blood vessels and supportive physical therapies:
- Long-term, persistent medical treatment first: Because the swelling has already become subacutely or chronically fibrotic, response to treatment is usually very slow. Continuous follow-up over many months is generally needed to reach the best clinical improvement.
- No high-heat invasive procedures: Ablative lasers, deep chemical peels, and focused energy treatments are avoided in areas of heavy tissue swelling, because they can trigger secondary inflammation and increase fluid leakage.
- Calming mast cell activity: Treatment does not stop at suppressing acne bacteria; it also targets the release of granules from mast cells in the skin.
Clinical Assessment & Diagnosis
Our assessment of a patient with Morbihan disease includes:
- Detailed history: When the acne or rosacea began, how the swelling developed, whether it varies over time or with the weather, and whether there is a history of allergy or use of medications that cause fluid retention.
- Focused examination: Identifying symmetrical or asymmetrical swelling on the forehead, eyelids, or cheeks; pressing firmly with a finger to confirm non-pitting edema; and checking the patient's field of vision to catch early drooping of the eyelids (ptosis) from severe swelling around the eyes.
- Dermoscopy: Shows background redness from dilated superficial vessels, follicular openings stretched by the swelling, and a tight, shiny surface that has lost its natural fine lines.
- Skin biopsy when needed: Histology shows edema of the superficial and deep dermis, dilated blood and lymphatic vessels, lymphohistiocytic infiltrates around vessels and follicles, and notably clusters of mast cells (identified with Giemsa or toluidine blue stains). A biopsy also helps exclude systemic granulomatous conditions such as orofacial granulomatosis, sarcoidosis, systemic lupus erythematosus (SLE), and Melkersson-Rosenthal syndrome.
Clinical Management & Treatment Protocol at Haute-Derma
Treatment aims to reduce fluid leaking from the vessels, restore lymphatic flow, and suppress fibrosis under the skin:
- Combined systemic medical therapy:
- Oral retinoids: Shrink the oil glands, suppress pro-inflammatory cytokines, and normalize the dermal extracellular matrix to relieve pressure on the lymphatic vessels.
- Anti-inflammatory systemic antibiotics (tetracyclines): Used because they inhibit matrix metalloproteinases (MMPs), helping protect the collagen around the lymphatic vessels and reduce local inflammation.
- Oral or intralesional corticosteroids: Given for short periods when swelling is progressing quickly, to rapidly calm mast cell inflammation and reduce acute swelling.
- Antihistamines with mast cell-stabilizing activity: Added long term to block the release of mediators that dilate vessels and drive fibroblasts toward fibrosis.
- Specialized recovery and mechanical drainage therapies:
- Manual lymphatic drainage (MLD): Specialized, very light massage strokes that follow the natural direction of lymph flow, moving trapped fluid toward nearby lymph nodes and easing tissue pressure.
- Red LED light (633 nm) combined with near-infrared (830 nm): Regular non-thermal sessions to soothe tissue inflammation, improve microcirculation, and support the healing of damaged connective tissue.
- Conservative surgery (surgical debulking/blepharoplasty): Considered after multidisciplinary review for severe fibrotic eyelid swelling that directly blocks vision and has not responded to prolonged systemic treatment.
